2007Taiwan Biobank國際研討會[議程]

2007.08.13 (Mon.) First Day　Time：08:15~16:30

08:15~09:00

Registration

09:00~09:10

Welcome and Opening Remarks / International conference hall
Hsu-Mei Hsu, Taiwan

Medical Genetics (MG) section / 1st Conference Room /
Chairman：Ding-Shinn Chen,Taiwan
Panel 1：Medical Research and Biobank I

09:10~10:00

UK Biobank: from concept to reality
Tim Sprosen, UK

10:00~10:15

Coffee Break

10:15~11:10

The Kadoorie Study: a large biobank project in 0.5M adult Chinese
Zheng-Ming Chen, UK

11:10~12:00

Genomic Medicine Research in Taiwan: Toward Personalized Medicine
Yuan-Tsong Chen, Taiwan

12:00~13:30

Lunch
Place: 4F Lounge

MG section / 1st Conference Room / Chairman：Chen-Yang Shen, Taiwan
Panel 2：Medical Research and Biobank II

Bio-IT section / 2nd Conference Room / Chairman：Gwo-Jiunn Huang, Taiwan
Panel 1：Current and Future Challenges of Biobank Information Technology

13:30~14:20

Genome Epidemiological Cohort Study in Korea
Keun-Young Yoo, Korea

Biobank Information Management System for the 21st century Biobanking
Jan-Eric Litton, Sweden

14:20~15:10

Karolinska Institutet Biobank: enabling infrastructure for public population projects
Gunnel Tybring, Sweden

From Biobanks to Biomarkers: The role of IT in the transformation of Life Sciences and Healthcare
Michael Hehenberger, USA

15:10~15:30

Coffee Break

15:30~16:30

The Estonian Genome Project as a population based biobank.
Andres Metspalu, Estonia

Developing IT Infrastructure of Taiwan Biobank - from Public Health Informatics Initiative
Belinda Chen, Taiwan

2007.08.14 (Tue.) Second Day　Time：08:30~17:30

08:30~09:00

Registration

MG section / 1st Conference Room / Chairman： Ling-Ling Hsieh & Chen-Yang Shen, Taiwan
Panel 3：Medical Research and Biobank III

Industrial Development (ID) section / 2nd Conference Room Chairman：Ming-Ki Wu, Taiwan
Panel 1：The prospect of biobank applications in terms of the biotechnology and pharmaceutical development value chain

09:00~09:40

The Strengths to Explore Genetic Susceptibility to Chronic Diseases in Taiwan
Chen-Yang Shen, Taiwan

Drug Discovery Journey with the Automated Ligand Identification System (ALIS): From High Throughput Screening to Hit-to-Lead Optimization
Cheng-Chi Chuang, USA

09:40~10:20

Genetic risk assessment for common complex diseases: experience of Two-township Study (CVDFACTS) and implications to Taiwan Biobank
Wen-Harn Pan, Taiwan

Biobanking in Contemporary? Biopharmaceutical? Research and Development
Michael J. Malinowski, USA

10:20~10:30

Coffee Break

10:30~11:00

From Biobanking to Biomarkers
Gerd Schmitz, Germany

Access and Intellectual Property Rights in UK Biobank: What are the Challenges and Options?
Graeme Laurie , UK

11:00~11:30

Pharmacogenomics in New Drug Development and Clinical Research
Albert Liou, Taiwan

11:30~13:00

Lunch
Place: 4F Lounge

ELSI section / 1st Conference Room / Chairman：Michael Cheng-tek Tai, Taiwan
Panel 1：Ethics in Biobanking

13:00~13:30

Bioethics of Biobank ELSI Issues in a Post-Sequence Era
Ryuich Ida, Japan

13:30~14:00

Ethics and Regulatory Frameworks for Biobanks: Safeguarding Altruism and Trust
Alastair V Campbell, Singapore

14:00~14:40

What kind of Trust do we need for Biobanking?
Shui-Chuen Lee, Taiwan

14:40~15:00

Coffee Break

ELSI section / 1st Conference Room / Chairman：Chang-fa Lo, Taiwan
Panel 2：Legislative Policy and Its Implementation

15:00~15:30

The Legislative Initiative for Taiwan BiobanK
Chien-Te Fan, Taiwan

15:30~16:00

Bioethics Concerns of Human DNA Collections:The National Laboratory for the Genetics of Israeli Populations
* David Gurwitz, Israel

16:00~16:30

The Legal Policy of Taiwan Biobank: Considerations and Reflections Chung-His Lee, Taiwan

16:40~17:30

Round Table Conference

* the presentation will be made via telephone

PROGRAM